Articles
| Open Access |
DOI: BIOCHEMICAL, IMMUNOLOGICAL, SEROLOGICAL INDICATORS FOR SERORESISTANT SYPHILIS, CORRECTION IN TREATMENT
K. A. Yuldashev , Professor, Supervisor: Doctor of Medical Sciences, Uzbekistan Abzoirov Kudrat Musulmanovich , Republican Scientific And Practical Medical Center For Dermatology And Venerology Ministry Of Health Of The Republic Of UzbekistanAbstract
In recent years, the world has seen a significant increase in the incidence of sexually transmitted infections, including syphilis. Despite the progress made in venereology, the problem of syphilis is an urgent problem of our time, and this especially concerns serological resistance in syphilis. Among practitioners and scientists involved in the treatment of syphilis, it is widely believed that there is an increase in the number of cases of seroresistance among patients treated for syphilis.
Keywords
Biochemical indicators, syphilis
References
Arifov S.S. Syphilis. Tashkent. 2001. p.146.
Averbaks M.M., Moroz A.M. Immunogenetics of infectious diseases Publisher: Meditsina. - 1985 256 p.,
Akovbyan V.A. Pharmacokinetic studies and results of a clinical study of extencillin. 1994;
Aleksandrov M.V., Piryatinskaya V.A., Sokolovsky V.V. The cyclic nature of the incidence of syphilis and nonspecific resistance of the macroorganism. – 1997
Amelina P.O. Serological resistance after treatment of acquired syphilis: current situation and prognosis: dissertation for the competition. cand. honey. Sciences. 2006
Bogush P.G., Vazhbin L.B., Chuksina Yu.Yu. Evaluation of immunological reactivity in patients with syphilis. 2003;
Borisenko K.K., Vinokurov I.N., Toporovsky L.M. Features of the course of latent forms of syphilis. 1989.
Article Statistics
Copyright License
Copyright (c) 2022 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.